Fresenius Medical Care reports that it is still in the process of securing U.S. Federal Trade Commission sign-off for its merger with NXStage Medical, adding that it expects the transaction to close in Q1 2019.
Previously: NxStage Medical under modest pressure on slow pace of acquirer Fresenius to work through U.S. antitrust issues; shares down a fraction (Dec. 14, 2017)
Date: January 7, 2019
Source: SeekingAlpha
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.